APA (7th ed.) Citation

Broyl, A., Corthals, S. L., Jongen, J. L., van der Holt, B., Kuiper, R., de Knegt, Y., . . . Sonneveld, P. (2010). Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: A prospective analysis of data from the HOVON-65/GMMG-HD4 trial. The lancet. Oncology, 11(11), . https://doi.org/10.1016/S1470-2045(10)70206-0

Chicago Style (17th ed.) Citation

Broyl, Annemiek, et al. "Mechanisms of Peripheral Neuropathy Associated with Bortezomib and Vincristine in Patients with Newly Diagnosed Multiple Myeloma: A Prospective Analysis of Data from the HOVON-65/GMMG-HD4 Trial." The Lancet. Oncology 11, no. 11 (2010). https://doi.org/10.1016/S1470-2045(10)70206-0.

MLA (9th ed.) Citation

Broyl, Annemiek, et al. "Mechanisms of Peripheral Neuropathy Associated with Bortezomib and Vincristine in Patients with Newly Diagnosed Multiple Myeloma: A Prospective Analysis of Data from the HOVON-65/GMMG-HD4 Trial." The Lancet. Oncology, vol. 11, no. 11, 2010, https://doi.org/10.1016/S1470-2045(10)70206-0.